nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS1—kidney cancer	0.514	0.636	CbGaD
Magnesium salicylate—PTGS2—kidney cancer	0.294	0.364	CbGaD
Magnesium salicylate—Trisalicylate-choline—PTGS1—kidney cancer	0.00144	0.192	CrCbGaD
Magnesium salicylate—Salicylate-sodium—PTGS1—kidney cancer	0.000871	0.117	CrCbGaD
Magnesium salicylate—Trisalicylate-choline—PTGS2—kidney cancer	0.000822	0.11	CrCbGaD
Magnesium salicylate—Nepafenac—PTGS1—kidney cancer	0.000611	0.0817	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS1—kidney cancer	0.000597	0.0799	CrCbGaD
Magnesium salicylate—Flushing—Sorafenib—kidney cancer	0.000546	0.00369	CcSEcCtD
Magnesium salicylate—Somnolence—Pazopanib—kidney cancer	0.000543	0.00367	CcSEcCtD
Magnesium salicylate—Dyspepsia—Pazopanib—kidney cancer	0.000537	0.00363	CcSEcCtD
Magnesium salicylate—Hepatitis—Dactinomycin—kidney cancer	0.000536	0.00362	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Sunitinib—kidney cancer	0.000536	0.00362	CcSEcCtD
Magnesium salicylate—Decreased appetite—Pazopanib—kidney cancer	0.000531	0.00358	CcSEcCtD
Magnesium salicylate—Flushing—Sunitinib—kidney cancer	0.000526	0.00355	CcSEcCtD
Magnesium salicylate—Pain—Pazopanib—kidney cancer	0.000522	0.00353	CcSEcCtD
Magnesium salicylate—Erythema—Sorafenib—kidney cancer	0.000513	0.00346	CcSEcCtD
Magnesium salicylate—Sweating—Vincristine—kidney cancer	0.000512	0.00346	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS1—kidney cancer	0.000508	0.0679	CrCbGaD
Magnesium salicylate—Erythema multiforme—Dactinomycin—kidney cancer	0.000507	0.00343	CcSEcCtD
Magnesium salicylate—Deafness—Capecitabine—kidney cancer	0.000505	0.00341	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Paclitaxel—kidney cancer	0.000502	0.00339	CcSEcCtD
Magnesium salicylate—Dysgeusia—Sorafenib—kidney cancer	0.000502	0.00339	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS2—kidney cancer	0.000498	0.0666	CrCbGaD
Magnesium salicylate—Flushing—Dactinomycin—kidney cancer	0.000498	0.00336	CcSEcCtD
Magnesium salicylate—Stinging—Doxorubicin—kidney cancer	0.000495	0.00334	CcSEcCtD
Magnesium salicylate—Erythema—Sunitinib—kidney cancer	0.000493	0.00333	CcSEcCtD
Magnesium salicylate—Sweating—Gemcitabine—kidney cancer	0.000485	0.00328	CcSEcCtD
Magnesium salicylate—Dysgeusia—Sunitinib—kidney cancer	0.000483	0.00326	CcSEcCtD
Magnesium salicylate—Oedema—Everolimus—kidney cancer	0.000482	0.00326	CcSEcCtD
Magnesium salicylate—Hallucination—Vincristine—kidney cancer	0.000477	0.00322	CcSEcCtD
Magnesium salicylate—Shock—Everolimus—kidney cancer	0.000474	0.0032	CcSEcCtD
Magnesium salicylate—Erythema—Dactinomycin—kidney cancer	0.000467	0.00315	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Everolimus—kidney cancer	0.000466	0.00315	CcSEcCtD
Magnesium salicylate—Oedema—Erlotinib—kidney cancer	0.000465	0.00314	CcSEcCtD
Magnesium salicylate—Anorexia—Vinblastine—kidney cancer	0.000461	0.00312	CcSEcCtD
Magnesium salicylate—Lethargy—Capecitabine—kidney cancer	0.000461	0.00311	CcSEcCtD
Magnesium salicylate—Anorexia—Everolimus—kidney cancer	0.000459	0.0031	CcSEcCtD
Magnesium salicylate—Pruritus—Temsirolimus—kidney cancer	0.000458	0.0031	CcSEcCtD
Magnesium salicylate—Shock—Erlotinib—kidney cancer	0.000457	0.00309	CcSEcCtD
Magnesium salicylate—Hypotension—Everolimus—kidney cancer	0.00045	0.00304	CcSEcCtD
Magnesium salicylate—Diarrhoea—Temsirolimus—kidney cancer	0.000443	0.00299	CcSEcCtD
Magnesium salicylate—Anorexia—Erlotinib—kidney cancer	0.000443	0.00299	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Doxorubicin—kidney cancer	0.000438	0.00296	CcSEcCtD
Magnesium salicylate—Weight increased—Paclitaxel—kidney cancer	0.000433	0.00292	CcSEcCtD
Magnesium salicylate—Pruritus—Pazopanib—kidney cancer	0.000432	0.00292	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Gemcitabine—kidney cancer	0.00043	0.0029	CcSEcCtD
Magnesium salicylate—Somnolence—Everolimus—kidney cancer	0.000428	0.00289	CcSEcCtD
Magnesium salicylate—Dizziness—Temsirolimus—kidney cancer	0.000428	0.00289	CcSEcCtD
Magnesium salicylate—Dyspepsia—Everolimus—kidney cancer	0.000424	0.00287	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vinblastine—kidney cancer	0.000421	0.00284	CcSEcCtD
Magnesium salicylate—Decreased appetite—Everolimus—kidney cancer	0.000419	0.00283	CcSEcCtD
Magnesium salicylate—Diarrhoea—Pazopanib—kidney cancer	0.000418	0.00282	CcSEcCtD
Magnesium salicylate—Constipation—Vinblastine—kidney cancer	0.000414	0.00279	CcSEcCtD
Magnesium salicylate—Pain—Vinblastine—kidney cancer	0.000414	0.00279	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Capecitabine—kidney cancer	0.000412	0.00279	CcSEcCtD
Magnesium salicylate—Constipation—Everolimus—kidney cancer	0.000412	0.00278	CcSEcCtD
Magnesium salicylate—Pain—Everolimus—kidney cancer	0.000412	0.00278	CcSEcCtD
Magnesium salicylate—Vomiting—Temsirolimus—kidney cancer	0.000412	0.00278	CcSEcCtD
Magnesium salicylate—Shock—Sorafenib—kidney cancer	0.000412	0.00278	CcSEcCtD
Magnesium salicylate—Dyspepsia—Erlotinib—kidney cancer	0.000409	0.00277	CcSEcCtD
Magnesium salicylate—Rash—Temsirolimus—kidney cancer	0.000408	0.00276	CcSEcCtD
Magnesium salicylate—Dermatitis—Temsirolimus—kidney cancer	0.000408	0.00276	CcSEcCtD
Magnesium salicylate—Headache—Temsirolimus—kidney cancer	0.000406	0.00274	CcSEcCtD
Magnesium salicylate—Decreased appetite—Erlotinib—kidney cancer	0.000404	0.00273	CcSEcCtD
Magnesium salicylate—Dizziness—Pazopanib—kidney cancer	0.000404	0.00273	CcSEcCtD
Magnesium salicylate—Oedema—Sunitinib—kidney cancer	0.000402	0.00272	CcSEcCtD
Magnesium salicylate—Epistaxis—Paclitaxel—kidney cancer	0.0004	0.0027	CcSEcCtD
Magnesium salicylate—Anorexia—Sorafenib—kidney cancer	0.000399	0.00269	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Vinblastine—kidney cancer	0.000399	0.00269	CcSEcCtD
Magnesium salicylate—Pain—Erlotinib—kidney cancer	0.000398	0.00269	CcSEcCtD
Magnesium salicylate—Constipation—Erlotinib—kidney cancer	0.000398	0.00269	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Everolimus—kidney cancer	0.000397	0.00268	CcSEcCtD
Magnesium salicylate—Shock—Sunitinib—kidney cancer	0.000396	0.00268	CcSEcCtD
Magnesium salicylate—Erythema—Gemcitabine—kidney cancer	0.000396	0.00267	CcSEcCtD
Magnesium salicylate—Asthma—Capecitabine—kidney cancer	0.00039	0.00264	CcSEcCtD
Magnesium salicylate—Vomiting—Pazopanib—kidney cancer	0.000388	0.00262	CcSEcCtD
Magnesium salicylate—Rash—Pazopanib—kidney cancer	0.000385	0.0026	CcSEcCtD
Magnesium salicylate—Nausea—Temsirolimus—kidney cancer	0.000385	0.0026	CcSEcCtD
Magnesium salicylate—Dermatitis—Pazopanib—kidney cancer	0.000384	0.0026	CcSEcCtD
Magnesium salicylate—Anorexia—Sunitinib—kidney cancer	0.000384	0.00259	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Doxorubicin—kidney cancer	0.000383	0.00259	CcSEcCtD
Magnesium salicylate—Headache—Pazopanib—kidney cancer	0.000382	0.00258	CcSEcCtD
Magnesium salicylate—Oedema—Dactinomycin—kidney cancer	0.000381	0.00257	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Capecitabine—kidney cancer	0.000374	0.00253	CcSEcCtD
Magnesium salicylate—Dyspepsia—Sorafenib—kidney cancer	0.000368	0.00249	CcSEcCtD
Magnesium salicylate—Oesophagitis—Doxorubicin—kidney cancer	0.000366	0.00248	CcSEcCtD
Magnesium salicylate—Decreased appetite—Sorafenib—kidney cancer	0.000364	0.00246	CcSEcCtD
Magnesium salicylate—Anorexia—Dactinomycin—kidney cancer	0.000363	0.00245	CcSEcCtD
Magnesium salicylate—Nausea—Pazopanib—kidney cancer	0.000363	0.00245	CcSEcCtD
Magnesium salicylate—Ecchymosis—Doxorubicin—kidney cancer	0.000362	0.00245	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Paclitaxel—kidney cancer	0.00036	0.00243	CcSEcCtD
Magnesium salicylate—Constipation—Sorafenib—kidney cancer	0.000358	0.00242	CcSEcCtD
Magnesium salicylate—Pain—Sorafenib—kidney cancer	0.000358	0.00242	CcSEcCtD
Magnesium salicylate—Weight increased—Capecitabine—kidney cancer	0.000355	0.0024	CcSEcCtD
Magnesium salicylate—Tinnitus—Paclitaxel—kidney cancer	0.000355	0.0024	CcSEcCtD
Magnesium salicylate—Dyspepsia—Sunitinib—kidney cancer	0.000354	0.00239	CcSEcCtD
Magnesium salicylate—Flushing—Paclitaxel—kidney cancer	0.000353	0.00239	CcSEcCtD
Magnesium salicylate—Decreased appetite—Sunitinib—kidney cancer	0.00035	0.00236	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—kidney cancer	0.000349	0.0467	CrCbGaD
Magnesium salicylate—Pain—Sunitinib—kidney cancer	0.000344	0.00233	CcSEcCtD
Magnesium salicylate—Constipation—Sunitinib—kidney cancer	0.000344	0.00233	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—kidney cancer	0.000341	0.0457	CrCbGaD
Magnesium salicylate—Pruritus—Everolimus—kidney cancer	0.000341	0.0023	CcSEcCtD
Magnesium salicylate—Oedema—Vincristine—kidney cancer	0.00034	0.0023	CcSEcCtD
Magnesium salicylate—Urticaria—Sorafenib—kidney cancer	0.000332	0.00225	CcSEcCtD
Magnesium salicylate—Erythema—Paclitaxel—kidney cancer	0.000331	0.00224	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dactinomycin—kidney cancer	0.000331	0.00224	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vinblastine—kidney cancer	0.000331	0.00224	CcSEcCtD
Magnesium salicylate—Diarrhoea—Everolimus—kidney cancer	0.00033	0.00223	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Vincristine—kidney cancer	0.000329	0.00222	CcSEcCtD
Magnesium salicylate—Pruritus—Erlotinib—kidney cancer	0.000329	0.00222	CcSEcCtD
Magnesium salicylate—Epistaxis—Capecitabine—kidney cancer	0.000328	0.00222	CcSEcCtD
Magnesium salicylate—Pain—Dactinomycin—kidney cancer	0.000326	0.0022	CcSEcCtD
Magnesium salicylate—Anorexia—Vincristine—kidney cancer	0.000325	0.00219	CcSEcCtD
Magnesium salicylate—Dysgeusia—Paclitaxel—kidney cancer	0.000324	0.00219	CcSEcCtD
Magnesium salicylate—Oedema—Gemcitabine—kidney cancer	0.000323	0.00218	CcSEcCtD
Magnesium salicylate—Dizziness—Vinblastine—kidney cancer	0.00032	0.00216	CcSEcCtD
Magnesium salicylate—Dizziness—Everolimus—kidney cancer	0.000319	0.00215	CcSEcCtD
Magnesium salicylate—Diarrhoea—Erlotinib—kidney cancer	0.000318	0.00215	CcSEcCtD
Magnesium salicylate—Hypotension—Vincristine—kidney cancer	0.000318	0.00215	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dactinomycin—kidney cancer	0.000314	0.00212	CcSEcCtD
Magnesium salicylate—Hepatitis—Capecitabine—kidney cancer	0.000312	0.00211	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS1—kidney cancer	0.000312	0.0418	CrCbGaD
Magnesium salicylate—Hyperhidrosis—Gemcitabine—kidney cancer	0.000312	0.00211	CcSEcCtD
Magnesium salicylate—Anorexia—Gemcitabine—kidney cancer	0.000308	0.00208	CcSEcCtD
Magnesium salicylate—Vomiting—Vinblastine—kidney cancer	0.000308	0.00208	CcSEcCtD
Magnesium salicylate—Dizziness—Erlotinib—kidney cancer	0.000307	0.00208	CcSEcCtD
Magnesium salicylate—Vomiting—Everolimus—kidney cancer	0.000306	0.00207	CcSEcCtD
Magnesium salicylate—Rash—Everolimus—kidney cancer	0.000304	0.00205	CcSEcCtD
Magnesium salicylate—Dermatitis—Everolimus—kidney cancer	0.000304	0.00205	CcSEcCtD
Magnesium salicylate—Headache—Vinblastine—kidney cancer	0.000303	0.00205	CcSEcCtD
Magnesium salicylate—Headache—Everolimus—kidney cancer	0.000302	0.00204	CcSEcCtD
Magnesium salicylate—Hypotension—Gemcitabine—kidney cancer	0.000302	0.00204	CcSEcCtD
Magnesium salicylate—Lethargy—Doxorubicin—kidney cancer	0.000297	0.00201	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vincristine—kidney cancer	0.000296	0.002	CcSEcCtD
Magnesium salicylate—Pruritus—Sorafenib—kidney cancer	0.000296	0.002	CcSEcCtD
Magnesium salicylate—Vomiting—Erlotinib—kidney cancer	0.000296	0.002	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Capecitabine—kidney cancer	0.000295	0.002	CcSEcCtD
Magnesium salicylate—Rash—Erlotinib—kidney cancer	0.000293	0.00198	CcSEcCtD
Magnesium salicylate—Dermatitis—Erlotinib—kidney cancer	0.000293	0.00198	CcSEcCtD
Magnesium salicylate—Headache—Erlotinib—kidney cancer	0.000291	0.00197	CcSEcCtD
Magnesium salicylate—Tinnitus—Capecitabine—kidney cancer	0.000291	0.00197	CcSEcCtD
Magnesium salicylate—Pain—Vincristine—kidney cancer	0.000291	0.00197	CcSEcCtD
Magnesium salicylate—Constipation—Vincristine—kidney cancer	0.000291	0.00197	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—kidney cancer	0.00029	0.0388	CrCbGaD
Magnesium salicylate—Flushing—Capecitabine—kidney cancer	0.00029	0.00196	CcSEcCtD
Magnesium salicylate—Nausea—Vinblastine—kidney cancer	0.000287	0.00194	CcSEcCtD
Magnesium salicylate—Somnolence—Gemcitabine—kidney cancer	0.000287	0.00194	CcSEcCtD
Magnesium salicylate—Nausea—Everolimus—kidney cancer	0.000286	0.00193	CcSEcCtD
Magnesium salicylate—Diarrhoea—Sorafenib—kidney cancer	0.000286	0.00193	CcSEcCtD
Magnesium salicylate—Pruritus—Sunitinib—kidney cancer	0.000285	0.00192	CcSEcCtD
Magnesium salicylate—Decreased appetite—Gemcitabine—kidney cancer	0.000281	0.0019	CcSEcCtD
Magnesium salicylate—Dizziness—Sorafenib—kidney cancer	0.000277	0.00187	CcSEcCtD
Magnesium salicylate—Pain—Gemcitabine—kidney cancer	0.000276	0.00187	CcSEcCtD
Magnesium salicylate—Constipation—Gemcitabine—kidney cancer	0.000276	0.00187	CcSEcCtD
Magnesium salicylate—Nausea—Erlotinib—kidney cancer	0.000276	0.00187	CcSEcCtD
Magnesium salicylate—Diarrhoea—Sunitinib—kidney cancer	0.000275	0.00186	CcSEcCtD
Magnesium salicylate—Confusional state—Paclitaxel—kidney cancer	0.000273	0.00184	CcSEcCtD
Magnesium salicylate—Erythema—Capecitabine—kidney cancer	0.000272	0.00184	CcSEcCtD
Magnesium salicylate—Oedema—Paclitaxel—kidney cancer	0.00027	0.00183	CcSEcCtD
Magnesium salicylate—Dysgeusia—Capecitabine—kidney cancer	0.000266	0.0018	CcSEcCtD
Magnesium salicylate—Dizziness—Sunitinib—kidney cancer	0.000266	0.0018	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Gemcitabine—kidney cancer	0.000266	0.0018	CcSEcCtD
Magnesium salicylate—Shock—Paclitaxel—kidney cancer	0.000266	0.0018	CcSEcCtD
Magnesium salicylate—Vomiting—Sorafenib—kidney cancer	0.000266	0.0018	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Doxorubicin—kidney cancer	0.000266	0.0018	CcSEcCtD
Magnesium salicylate—Rash—Sorafenib—kidney cancer	0.000264	0.00178	CcSEcCtD
Magnesium salicylate—Dermatitis—Sorafenib—kidney cancer	0.000263	0.00178	CcSEcCtD
Magnesium salicylate—Headache—Sorafenib—kidney cancer	0.000262	0.00177	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000261	0.00177	CcSEcCtD
Magnesium salicylate—Diarrhoea—Dactinomycin—kidney cancer	0.000261	0.00176	CcSEcCtD
Magnesium salicylate—Anorexia—Paclitaxel—kidney cancer	0.000258	0.00174	CcSEcCtD
Magnesium salicylate—Vomiting—Sunitinib—kidney cancer	0.000256	0.00173	CcSEcCtD
Magnesium salicylate—Rash—Sunitinib—kidney cancer	0.000254	0.00171	CcSEcCtD
Magnesium salicylate—Dermatitis—Sunitinib—kidney cancer	0.000254	0.00171	CcSEcCtD
Magnesium salicylate—Hypotension—Paclitaxel—kidney cancer	0.000253	0.00171	CcSEcCtD
Magnesium salicylate—Headache—Sunitinib—kidney cancer	0.000252	0.0017	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—kidney cancer	0.000252	0.0017	CcSEcCtD
Magnesium salicylate—Nausea—Sorafenib—kidney cancer	0.000248	0.00168	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS1—kidney cancer	0.000248	0.0331	CrCbGaD
Magnesium salicylate—Vomiting—Dactinomycin—kidney cancer	0.000242	0.00164	CcSEcCtD
Magnesium salicylate—Somnolence—Paclitaxel—kidney cancer	0.00024	0.00162	CcSEcCtD
Magnesium salicylate—Rash—Dactinomycin—kidney cancer	0.00024	0.00162	CcSEcCtD
Magnesium salicylate—Nausea—Sunitinib—kidney cancer	0.000239	0.00162	CcSEcCtD
Magnesium salicylate—Dyspepsia—Paclitaxel—kidney cancer	0.000238	0.00161	CcSEcCtD
Magnesium salicylate—Decreased appetite—Paclitaxel—kidney cancer	0.000235	0.00159	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vincristine—kidney cancer	0.000233	0.00157	CcSEcCtD
Magnesium salicylate—Pain—Paclitaxel—kidney cancer	0.000231	0.00156	CcSEcCtD
Magnesium salicylate—Constipation—Paclitaxel—kidney cancer	0.000231	0.00156	CcSEcCtD
Magnesium salicylate—Weight increased—Doxorubicin—kidney cancer	0.000229	0.00155	CcSEcCtD
Magnesium salicylate—Pruritus—Gemcitabine—kidney cancer	0.000228	0.00154	CcSEcCtD
Magnesium salicylate—Nausea—Dactinomycin—kidney cancer	0.000226	0.00153	CcSEcCtD
Magnesium salicylate—Dizziness—Vincristine—kidney cancer	0.000225	0.00152	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—kidney cancer	0.000224	0.00152	CcSEcCtD
Magnesium salicylate—Confusional state—Capecitabine—kidney cancer	0.000224	0.00151	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Paclitaxel—kidney cancer	0.000223	0.00151	CcSEcCtD
Magnesium salicylate—Oedema—Capecitabine—kidney cancer	0.000222	0.0015	CcSEcCtD
Magnesium salicylate—Diarrhoea—Gemcitabine—kidney cancer	0.000221	0.00149	CcSEcCtD
Magnesium salicylate—Shock—Capecitabine—kidney cancer	0.000218	0.00147	CcSEcCtD
Magnesium salicylate—Vomiting—Vincristine—kidney cancer	0.000216	0.00146	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—kidney cancer	0.000215	0.00145	CcSEcCtD
Magnesium salicylate—Urticaria—Paclitaxel—kidney cancer	0.000215	0.00145	CcSEcCtD
Magnesium salicylate—Rash—Vincristine—kidney cancer	0.000215	0.00145	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Capecitabine—kidney cancer	0.000215	0.00145	CcSEcCtD
Magnesium salicylate—Dermatitis—Vincristine—kidney cancer	0.000214	0.00145	CcSEcCtD
Magnesium salicylate—Headache—Vincristine—kidney cancer	0.000213	0.00144	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—kidney cancer	0.000212	0.00143	CcSEcCtD
Magnesium salicylate—Anorexia—Capecitabine—kidney cancer	0.000212	0.00143	CcSEcCtD
Magnesium salicylate—Hypotension—Capecitabine—kidney cancer	0.000207	0.0014	CcSEcCtD
Magnesium salicylate—Vomiting—Gemcitabine—kidney cancer	0.000205	0.00139	CcSEcCtD
Magnesium salicylate—Rash—Gemcitabine—kidney cancer	0.000204	0.00138	CcSEcCtD
Magnesium salicylate—Dermatitis—Gemcitabine—kidney cancer	0.000203	0.00137	CcSEcCtD
Magnesium salicylate—Headache—Gemcitabine—kidney cancer	0.000202	0.00137	CcSEcCtD
Magnesium salicylate—Nausea—Vincristine—kidney cancer	0.000202	0.00137	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—kidney cancer	0.000201	0.00136	CcSEcCtD
Magnesium salicylate—Dyspepsia—Capecitabine—kidney cancer	0.000195	0.00132	CcSEcCtD
Magnesium salicylate—Decreased appetite—Capecitabine—kidney cancer	0.000193	0.0013	CcSEcCtD
Magnesium salicylate—Nausea—Gemcitabine—kidney cancer	0.000192	0.0013	CcSEcCtD
Magnesium salicylate—Pruritus—Paclitaxel—kidney cancer	0.000191	0.00129	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Doxorubicin—kidney cancer	0.00019	0.00129	CcSEcCtD
Magnesium salicylate—Constipation—Capecitabine—kidney cancer	0.00019	0.00128	CcSEcCtD
Magnesium salicylate—Pain—Capecitabine—kidney cancer	0.00019	0.00128	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—kidney cancer	0.000188	0.00127	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—kidney cancer	0.000187	0.00126	CcSEcCtD
Magnesium salicylate—Diarrhoea—Paclitaxel—kidney cancer	0.000185	0.00125	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Capecitabine—kidney cancer	0.000183	0.00124	CcSEcCtD
Magnesium salicylate—Dizziness—Paclitaxel—kidney cancer	0.000179	0.00121	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—kidney cancer	0.000178	0.0239	CrCbGaD
Magnesium salicylate—Urticaria—Capecitabine—kidney cancer	0.000176	0.00119	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—kidney cancer	0.000175	0.00118	CcSEcCtD
Magnesium salicylate—Vomiting—Paclitaxel—kidney cancer	0.000172	0.00116	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—kidney cancer	0.000172	0.00116	CcSEcCtD
Magnesium salicylate—Rash—Paclitaxel—kidney cancer	0.00017	0.00115	CcSEcCtD
Magnesium salicylate—Dermatitis—Paclitaxel—kidney cancer	0.00017	0.00115	CcSEcCtD
Magnesium salicylate—Headache—Paclitaxel—kidney cancer	0.000169	0.00114	CcSEcCtD
Magnesium salicylate—Nausea—Paclitaxel—kidney cancer	0.000161	0.00109	CcSEcCtD
Magnesium salicylate—Pruritus—Capecitabine—kidney cancer	0.000157	0.00106	CcSEcCtD
Magnesium salicylate—Diarrhoea—Capecitabine—kidney cancer	0.000152	0.00103	CcSEcCtD
Magnesium salicylate—Salicylic acid—ABCB1—kidney cancer	0.000152	0.0203	CrCbGaD
Magnesium salicylate—Dizziness—Capecitabine—kidney cancer	0.000147	0.000991	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—kidney cancer	0.000144	0.000974	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—kidney cancer	0.000143	0.000966	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—kidney cancer	0.000142	0.0189	CrCbGaD
Magnesium salicylate—Vomiting—Capecitabine—kidney cancer	0.000141	0.000953	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—kidney cancer	0.000141	0.000951	CcSEcCtD
Magnesium salicylate—Rash—Capecitabine—kidney cancer	0.00014	0.000945	CcSEcCtD
Magnesium salicylate—Dermatitis—Capecitabine—kidney cancer	0.00014	0.000944	CcSEcCtD
Magnesium salicylate—Headache—Capecitabine—kidney cancer	0.000139	0.000939	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—kidney cancer	0.000138	0.000934	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—kidney cancer	0.000136	0.000921	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—kidney cancer	0.000134	0.000903	CcSEcCtD
Magnesium salicylate—Nausea—Capecitabine—kidney cancer	0.000132	0.00089	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—kidney cancer	0.000127	0.000859	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—kidney cancer	0.000126	0.000851	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—kidney cancer	0.000124	0.00084	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—kidney cancer	0.000122	0.000826	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—kidney cancer	0.000122	0.000826	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—kidney cancer	0.000118	0.000796	CcSEcCtD
Magnesium salicylate—Carbamazepine—ABCB1—kidney cancer	0.000117	0.0156	CrCbGaD
Magnesium salicylate—Urticaria—Doxorubicin—kidney cancer	0.000114	0.000768	CcSEcCtD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000102	0.00275	CbGpPWpGaD
Magnesium salicylate—Pruritus—Doxorubicin—kidney cancer	0.000101	0.000684	CcSEcCtD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.0001	0.00271	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	9.84e-05	0.00266	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Doxorubicin—kidney cancer	9.79e-05	0.000661	CcSEcCtD
Magnesium salicylate—PTGS1—Biological oxidations—GSTM1—kidney cancer	9.72e-05	0.00263	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	9.64e-05	0.0026	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—RELA—kidney cancer	9.58e-05	0.00259	CbGpPWpGaD
Magnesium salicylate—Dizziness—Doxorubicin—kidney cancer	9.46e-05	0.000639	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	9.36e-05	0.00253	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	9.25e-05	0.0025	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP1A1—kidney cancer	9.21e-05	0.00249	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	9.19e-05	0.00248	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	9.19e-05	0.00248	CbGpPWpGaD
Magnesium salicylate—Vomiting—Doxorubicin—kidney cancer	9.09e-05	0.000614	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	9.05e-05	0.00245	CbGpPWpGaD
Magnesium salicylate—Rash—Doxorubicin—kidney cancer	9.02e-05	0.000609	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—kidney cancer	9.01e-05	0.000609	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—kidney cancer	8.96e-05	0.000605	CcSEcCtD
Magnesium salicylate—ALB—Hemostasis—L1CAM—kidney cancer	8.9e-05	0.0024	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	8.86e-05	0.00239	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	8.79e-05	0.00238	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	8.59e-05	0.00232	CbGpPWpGaD
Magnesium salicylate—Nausea—Doxorubicin—kidney cancer	8.5e-05	0.000574	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	8.37e-05	0.00226	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	8.25e-05	0.00223	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ACY1—kidney cancer	8.1e-05	0.00219	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.1e-05	0.00219	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—RELA—kidney cancer	7.79e-05	0.00211	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	7.77e-05	0.0021	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	7.65e-05	0.00207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	7.55e-05	0.00204	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	7.48e-05	0.00202	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	7.31e-05	0.00197	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	7.31e-05	0.00197	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL2—kidney cancer	7.02e-05	0.0019	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	6.97e-05	0.00188	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.91e-05	0.00187	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PDHB—kidney cancer	6.89e-05	0.00186	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—POMC—kidney cancer	6.87e-05	0.00186	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ANXA2—kidney cancer	6.74e-05	0.00182	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CCBL1—kidney cancer	6.48e-05	0.00175	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ACY1—kidney cancer	6.43e-05	0.00174	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—RELA—kidney cancer	6.19e-05	0.00167	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CCBL1—kidney cancer	6.14e-05	0.00166	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	6.06e-05	0.00164	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	6.01e-05	0.00163	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.86e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	5.85e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.84e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.84e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.84e-05	0.00158	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GLIPR1—kidney cancer	5.62e-05	0.00152	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPAT—kidney cancer	5.62e-05	0.00152	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	5.59e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KCNMA1—kidney cancer	5.59e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	5.57e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AMER1—kidney cancer	5.55e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.55e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.49e-05	0.00148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PDHB—kidney cancer	5.47e-05	0.00148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL2—kidney cancer	5.45e-05	0.00147	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	5.41e-05	0.00146	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	5.31e-05	0.00144	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	5.27e-05	0.00142	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APRT—kidney cancer	5.22e-05	0.00141	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—FH—kidney cancer	5.22e-05	0.00141	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ACY1—kidney cancer	5.2e-05	0.00141	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	5.17e-05	0.0014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CCBL1—kidney cancer	5.14e-05	0.00139	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—kidney cancer	5.11e-05	0.00138	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.1e-05	0.00138	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GPC3—kidney cancer	4.91e-05	0.00133	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—GRB7—kidney cancer	4.88e-05	0.00132	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	4.87e-05	0.00132	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA2—kidney cancer	4.78e-05	0.00129	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALAD—kidney cancer	4.65e-05	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GPC3—kidney cancer	4.65e-05	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.65e-05	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ST3GAL2—kidney cancer	4.54e-05	0.00123	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITPR2—kidney cancer	4.53e-05	0.00122	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—kidney cancer	4.51e-05	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPAT—kidney cancer	4.46e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GLIPR1—kidney cancer	4.46e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.44e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.44e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PDHB—kidney cancer	4.43e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.4e-05	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.38e-05	0.00118	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.36e-05	0.00118	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ST3GAL2—kidney cancer	4.31e-05	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—kidney cancer	4.26e-05	0.00115	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PGK1—kidney cancer	4.26e-05	0.00115	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC5A3—kidney cancer	4.26e-05	0.00115	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—LDHB—kidney cancer	4.17e-05	0.00113	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.17e-05	0.00113	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CCBL1—kidney cancer	4.16e-05	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APRT—kidney cancer	4.15e-05	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—FH—kidney cancer	4.15e-05	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.13e-05	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.09e-05	0.00111	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.05e-05	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SLC5A3—kidney cancer	4.03e-05	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PGK1—kidney cancer	4.03e-05	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SFRP2—kidney cancer	3.96e-05	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LDHB—kidney cancer	3.96e-05	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GPC3—kidney cancer	3.9e-05	0.00105	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA2—kidney cancer	3.79e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.79e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.76e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALAD—kidney cancer	3.69e-05	0.000998	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TCEB2—kidney cancer	3.69e-05	0.000997	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TCEB1—kidney cancer	3.69e-05	0.000997	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA9—kidney cancer	3.62e-05	0.000978	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.61e-05	0.000977	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GLIPR1—kidney cancer	3.61e-05	0.000975	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPAT—kidney cancer	3.61e-05	0.000975	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.61e-05	0.000975	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.61e-05	0.000974	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.58e-05	0.000967	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.56e-05	0.000962	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.54e-05	0.000956	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.53e-05	0.000953	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.52e-05	0.000952	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.5e-05	0.000946	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.49e-05	0.000943	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PGK1—kidney cancer	3.38e-05	0.000913	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC5A3—kidney cancer	3.38e-05	0.000913	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APRT—kidney cancer	3.35e-05	0.000906	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—FH—kidney cancer	3.35e-05	0.000906	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA1—kidney cancer	3.33e-05	0.000899	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—LDHB—kidney cancer	3.31e-05	0.000896	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.28e-05	0.000886	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GPC3—kidney cancer	3.15e-05	0.000852	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.15e-05	0.000851	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA2—kidney cancer	3.1e-05	0.000837	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.08e-05	0.000832	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CRABP1—kidney cancer	3.08e-05	0.000832	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA2—kidney cancer	3.07e-05	0.000829	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RPL14—kidney cancer	3e-05	0.00081	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALAD—kidney cancer	2.99e-05	0.000808	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.98e-05	0.000805	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.98e-05	0.000804	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.97e-05	0.000803	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ST3GAL2—kidney cancer	2.92e-05	0.000788	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.9e-05	0.000783	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA9—kidney cancer	2.87e-05	0.000776	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ITPR2—kidney cancer	2.86e-05	0.000773	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ALDH1A1—kidney cancer	2.85e-05	0.000771	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.84e-05	0.000766	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.81e-05	0.000759	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IGF2—kidney cancer	2.79e-05	0.000753	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC5A3—kidney cancer	2.73e-05	0.000739	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PGK1—kidney cancer	2.73e-05	0.000739	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ITPR2—kidney cancer	2.71e-05	0.000733	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—LDHB—kidney cancer	2.68e-05	0.000725	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.68e-05	0.000724	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.67e-05	0.000721	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.64e-05	0.000713	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ACHE—kidney cancer	2.61e-05	0.000705	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTT1—kidney cancer	2.61e-05	0.000705	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SCARB1—kidney cancer	2.47e-05	0.000667	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.46e-05	0.000665	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CRABP1—kidney cancer	2.44e-05	0.00066	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSMD7—kidney cancer	2.4e-05	0.000648	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.38e-05	0.000643	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.35e-05	0.000634	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA9—kidney cancer	2.32e-05	0.000628	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—BCHE—kidney cancer	2.27e-05	0.000614	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSMD7—kidney cancer	2.27e-05	0.000614	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.27e-05	0.000614	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ITPR2—kidney cancer	2.27e-05	0.000614	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.27e-05	0.000613	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC5A5—kidney cancer	2.25e-05	0.000607	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC2A1—kidney cancer	2.17e-05	0.000586	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.15e-05	0.00058	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.1e-05	0.000568	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.09e-05	0.000566	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—kidney cancer	2.07e-05	0.00056	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ACHE—kidney cancer	2.07e-05	0.00056	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SLC2A1—kidney cancer	2.06e-05	0.000555	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.04e-05	0.000552	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JUNB—kidney cancer	2.04e-05	0.000551	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CRABP1—kidney cancer	1.98e-05	0.000534	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SCARB1—kidney cancer	1.96e-05	0.00053	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTGS1—kidney cancer	1.94e-05	0.000524	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSMD7—kidney cancer	1.9e-05	0.000514	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ITPR2—kidney cancer	1.84e-05	0.000497	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.83e-05	0.000496	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—kidney cancer	1.81e-05	0.000489	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BCHE—kidney cancer	1.8e-05	0.000488	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC5A5—kidney cancer	1.78e-05	0.000482	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.77e-05	0.000479	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC2A1—kidney cancer	1.72e-05	0.000465	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCB1—kidney cancer	1.71e-05	0.000463	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.69e-05	0.000458	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ACHE—kidney cancer	1.68e-05	0.000453	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—kidney cancer	1.68e-05	0.000453	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTM1—kidney cancer	1.66e-05	0.000449	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN2B—kidney cancer	1.66e-05	0.000449	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SCARB1—kidney cancer	1.59e-05	0.000429	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1A1—kidney cancer	1.58e-05	0.000426	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS1—kidney cancer	1.57e-05	0.000424	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSMD7—kidney cancer	1.54e-05	0.000416	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAF1—kidney cancer	1.53e-05	0.000415	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BCHE—kidney cancer	1.46e-05	0.000394	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.46e-05	0.000394	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC5A5—kidney cancer	1.44e-05	0.00039	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—kidney cancer	1.44e-05	0.000388	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC2A1—kidney cancer	1.39e-05	0.000376	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—kidney cancer	1.38e-05	0.000372	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCB1—kidney cancer	1.36e-05	0.000367	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.35e-05	0.000365	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.33e-05	0.000359	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIF1A—kidney cancer	1.33e-05	0.000359	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TSC2—kidney cancer	1.32e-05	0.000358	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTM1—kidney cancer	1.32e-05	0.000357	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.29e-05	0.00035	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1A1—kidney cancer	1.25e-05	0.000338	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.18e-05	0.000318	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—POMC—kidney cancer	1.17e-05	0.000317	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APC—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KIT—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—kidney cancer	1.17e-05	0.000316	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—kidney cancer	1.16e-05	0.000314	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK3—kidney cancer	1.11e-05	0.000299	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BRAF—kidney cancer	1.1e-05	0.000297	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCB1—kidney cancer	1.1e-05	0.000297	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTM1—kidney cancer	1.07e-05	0.000288	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK1—kidney cancer	1.05e-05	0.000284	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.03e-05	0.000278	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1A1—kidney cancer	1.01e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—kidney cancer	9.94e-06	0.000269	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—kidney cancer	9.37e-06	0.000253	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—POMC—kidney cancer	9.32e-06	0.000252	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RAF1—kidney cancer	9.18e-06	0.000248	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—kidney cancer	9.13e-06	0.000247	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB2—kidney cancer	9.08e-06	0.000245	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTOR—kidney cancer	8.96e-06	0.000242	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD4—kidney cancer	8.95e-06	0.000242	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—kidney cancer	8.83e-06	0.000239	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—kidney cancer	8.41e-06	0.000227	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.31e-06	0.000225	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—kidney cancer	8.17e-06	0.000221	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CTNNB1—kidney cancer	7.95e-06	0.000215	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—kidney cancer	7.75e-06	0.000209	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—POMC—kidney cancer	7.54e-06	0.000204	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAPK3—kidney cancer	6.62e-06	0.000179	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—kidney cancer	6.49e-06	0.000175	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—kidney cancer	6.44e-06	0.000174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAPK1—kidney cancer	6.3e-06	0.00017	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—kidney cancer	6.02e-06	0.000163	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—kidney cancer	5.95e-06	0.000161	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—kidney cancer	5.76e-06	0.000156	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—kidney cancer	5.46e-06	0.000148	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—kidney cancer	5.25e-06	0.000142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—kidney cancer	4.58e-06	0.000124	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—kidney cancer	3.7e-06	0.0001	CbGpPWpGaD
